AVADEL PHARMACEUTICALS PLC Insider Trading Activity
Every SEC Form 4 insider transaction reported for AVADEL PHARMACEUTICALS PLC (AVDL), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are AVDL insiders buying or selling?
AVADEL PHARMACEUTICALS PLC insiders reported 45 open-market buys ($4.4M) and 9 sells ($235.7M) across 54 Form 4 filings — a net selling position of $231.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 18, 2026)
Insider sentiment
Net sellingNet insider flow of $231.3M in net selling.
Recent AVDL insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Weiss Asset Management LP | Other | Sale | 11.1M | $21.00 | $233.4M |
| Jan 22, 2025 | Linda Palczuk | Director | Purchase | 5.0K | $7.93 | $39.6K |
| Jan 14, 2025 | Peter J. Thornton | Director | Purchase | 10.0K | $8.05 | $80.5K |
| Jan 14, 2025 | Eric J Ende | Director | Purchase | 30.0K | $7.84 | $235.2K |
| Dec 16, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.3K | $10.44 | $24.0K |
| Dec 12, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 5.0K | $10.49 | $52.4K |
| Dec 10, 2024 | Gregory J Divis | Chief Executive Officer | Purchase | 10.0K | $9.97 | $99.7K |
| Dec 10, 2024 | Geoffrey Michael Glass | Director | Purchase | 20.3K | $9.84 | $199.6K |
| Dec 10, 2024 | Linda Palczuk | Director | Purchase | 3.0K | $10.19 | $30.6K |
| Jan 16, 2024 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.0K | $14.50 | $29.0K |
| Dec 29, 2023 | Mark Anthony Mccamish | Director | Sale | 75.0K | $14.53 | $1.1M |
| Aug 15, 2023 | Mark Anthony Mccamish | Director | Sale | 29.0K | $14.93 | $432.6K |
| Aug 14, 2023 | Thomas S Mchugh | Chief Financial Officer | Purchase | 2.0K | $14.45 | $28.9K |
| Aug 11, 2023 | Geoffrey Michael Glass | Director | Purchase | 14.0K | $13.40 | $187.6K |
| Aug 10, 2023 | Gregory J Divis | Chief Executive Officer | Purchase | 10.0K | $13.20 | $132.0K |
| May 19, 2023 | Eric J Ende | Director | Purchase | 13.0K | $13.93 | $181.1K |
| May 10, 2023 | Linda Palczuk | Director | Purchase | 2.5K | $14.76 | $36.9K |
| Dec 28, 2022 | Linda Palczuk | Director | Purchase | 2.0K | $7.20 | $14.4K |
| Nov 30, 2022 | Thomas S Mchugh | Chief Financial Officer | Purchase | 5.0K | $7.80 | $39.0K |
| Nov 23, 2022 | Eric J Ende | Director | Purchase | 20.0K | $7.80 | $156.1K |
| Jun 3, 2022 | Geoffrey Michael Glass | Director | Purchase | 45.0K | $2.14 | $96.3K |
| Jun 2, 2022 | Geoffrey Michael Glass | Director | Purchase | 45.0K | $2.14 | $96.3K |
| Jun 1, 2022 | Eric J Ende | Director | Purchase | 35.0K | $2.23 | $77.9K |
| May 31, 2022 | Linda Palczuk | Director | Purchase | 10.0K | $1.60 | $16.0K |
| May 31, 2022 | Thomas S Mchugh | Chief Financial Officer | Purchase | 50.0K | $2.14 | $106.9K |
Showing the 25 most recent of 54 Form 4 filings for AVADEL PHARMACEUTICALS PLC.
Most active AVDL insiders
- Eric J Ende10 filings
- Thomas S Mchugh9 filings
- Geoffrey Michael Glass7 filings
- Linda Palczuk7 filings
- Gregory J Divis6 filings
Ask anything about AVDL insider activity
Use Trabud's AI agent to query AVADEL PHARMACEUTICALS PLC's Form 4 history in plain English — "Show me AVDL CEO purchases this year" or compare it against any other ticker.
Open the AI agentAVDL insider trading FAQ
Are AVADEL PHARMACEUTICALS PLC insiders buying or selling?
Across 54 SEC Form 4 filings, AVADEL PHARMACEUTICALS PLC (AVDL) insiders reported 45 open-market purchases totaling $4.4M and 9 sales totaling $235.7M. That is a net selling position of $231.3M.
How many insiders trade AVDL stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AVADEL PHARMACEUTICALS PLC. The most recent filing was accepted on Feb 18, 2026.
Where does Trabud get AVDL insider trading data?
All AVDL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.